Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Healthcare Drug Manufacturers - Specialty & Generic
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face... see more

Current News (TSX:CPH)

Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings

Canada NewsWire March 12, 2026

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

Canada NewsWire March 4, 2026

Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)

Canada NewsWire January 28, 2026

Cipher Pharmaceuticals Reports Third Quarter 2025 Results

Canada NewsWire November 6, 2025

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

Canada NewsWire October 29, 2025

Cipher Pharmaceuticals Receives Successful Arbitration Award

Canada NewsWire October 14, 2025

Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

Canada NewsWire August 26, 2025

Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue

Canada NewsWire August 7, 2025

Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call

Canada NewsWire July 29, 2025
View More News ››

Opinion & Analysis (TSX:CPH)

Morning Market Outlook for Aug. 1, 2024

TheUpTrend August 1, 2024

Embrace low-cap biotech for high gains: Eden Rahim of Next Edge Capital

The Life Sciences Report March 2, 2016

How Cipher Pharmaceuticals Is Developing Products for Dermatological Disorders

Dan Levy November 16, 2015

Stockhouse Research: DirectCash craziness and Cipher generic drug battles

Chris Parry September 19, 2013
View More Opinion ››

Bullboard Posts (TSX:CPH)

Another View of Earnings

Clearly the Street was very impressed with CPH's Q4 and YE earnings that were released on Friday (up 17% despite another tough day in...
retiredcf - March 22, 2026

RE:RE:Keystone Financial

I saw them speak about CPH 10 bagger. They were talking about from the recommended price. I believe it was around $4.30. So they are...
Nelwyn - March 16, 2026

RE:Keystone Financial

10 bagger from current prices?  Or did they mean it has already done a 10 bagger haha
Daudau11 - March 16, 2026

Keystone Financial

Late last year, CPH was one of companies that they thought might be a potential 10 bagger over the next few years so there's little...
retiredcf - March 15, 2026

RE:Deception.

Apparently, the market wasn't disappointed today. While total revenue only grew 3% YoY, Natroba revenue grew 14% and will likely...
drewmumaw - March 13, 2026

Dean @PettyCash substack

Cipher Pharmaceuticals Q4 2025 Update – CPH.TO Execution Continues as the Balance Sheet Rapidly De-Risks ...
Possibleidiot01 - March 13, 2026
View more Bullboard ››

Geodrill Limited

Geodrill Limited

Geodrill Limited, together with its subsidiaries, provides mineral exploration drilling services to the mining companies in ...
View More »

Podcasts